Jane Street’s AEON Biopharma AEON Stock Holding History

Jane Street’s Portfolio AEON Stock Details AEON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-16,376	Closed	-$16.1K	–	11414
2026 Q1	$16.1K	Buy	+16,376	New	+$18.3K	﹤0.01%	11233
2025 Q4	–	Sell	-10,420	Closed	-$8.43K	–	10980
2025 Q3	$8.43K	Buy	+10,420	New	+$8.03K	﹤0.01%	10587
2025 Q1	–	Sell	-153	Closed	-$5.95K	–	9305
2024 Q4	$5.95K	Buy	153 +4	+3%	+$233	﹤0.01%	9213
2024 Q3	$11.2K	Sell	149 -174	-54%	-$15.3K	﹤0.01%	9344
2024 Q2	$24.4K	Sell	323 -180	-36%	-$42.9K	﹤0.01%	9024
2024 Q1	$421K	Buy	+503	New	+$364K	﹤0.01%	6990

Other funds holding AEON

DIG

Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BOCH

Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return

FAM

Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return

StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Jane Street's AEON Position: Q2 2026 in Review

Jane Street sold out of AEON Biopharma (AEON) in Q2 2026, closing a stake of 16,376 shares — an estimated $16.1K sold.

Jane Street first reported a position in AEON in Q1 2024 and held it in 6 quarters. The position peaked at $421K in Q1 2024. 22 funds tracked by Wall St. Rank hold AEON as of Q2 2026.

Jane Street reported no remaining AEON Biopharma position as of Q2 2026 after selling out during the quarter.
Jane Street sold 16,376 AEON Biopharma shares in Q2 2026, an estimated $16.1K.
Jane Street first reported a position in AEON Biopharma in Q1 2024 and held it in 6 quarters.
Jane Street's AEON Biopharma position peaked at $421K in Q1 2024.
22 funds tracked by Wall St. Rank held AEON Biopharma as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.